Republic Republic Republic
  • Log in
Open account
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Trading Buy and sell Republic Note Own a piece of Republic's upside
Republic Ventures Opportunities for accredited investors
Republic Capital Multi-stage venture firm
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US

  • Log in
  • Open account
All investors
Primary market Live deals Trading Buy and sell
Republic Note Own a piece of Republic's upside
Accredited only
Republic Ventures Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets
Tokenization Deploy your assets on-chain
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services
Insights

Founders

· November 22, 2017

Michael Lui, RMR Laboratories

  • Liked
    Like
    8
  • Comments (4)

Michael Lui, an army veteran and the founder of RMR Laboratories, is tackling the ongoing opioid crisis with cutting edge medical technology. With their first product group, topical creams, RMR Laboratories offers safe, effective solutions to consumers seeking cannabis as a pain management solution. Michael tells us what it’s like to build such an exciting startup that has the potential to better so many lives.

What is your business, and what problem you are solving?

RMR Laboratories is an R&D company that develops health and wellness applications using cannabis derivatives.

While there is significant interest in using cannabis to soothe health ailments, there aren’t any cannabis products in the market that are safe, effective, and convenient for people to use everyday. There just isn’t enough real science underlying current cannabis products, which is partly due to the regulatory history of the industry.

Even with changing attitudes towards cannabis as a way to manage pain, there’s a gap in the market. Until you have a series of products that are effective, safe and tailored for the mass market, you’ll see a gap between widespread acceptance and products that people want to use.

Our first chronic pain treatment product combines cannabidiol (CBD) with a proprietary, patented technology that delivers cannabinoids through the skin. The transdermal technology has been proven to deliver ingredients 5-25mm below the surface of the skin. That means we finally have a third way to harness the therapeutic power of cannabis and deliver it to the places where people need it. And because it’s a cream and CBD-based, the product is convenient to use without any psychoactive properties.

What inspired you to start your company?

I am an Army veteran and an amateur athlete, leaving me with wear and tear on my body. Several people I knew were using cannabis to treat their health ailments. I was curious whether cannabis would help me, but I don’t like to smoke and found ingesting cannabis very inconsistent. Neither of those two methods addressed the source of my pain, they just distracted me from it.  In addition, the topicals in the market are mostly just novelty items. The actual concentration of active ingredients, CBD or THC, are often less than 1%.

At the time I was researching about cannabis to remedy pain, I also learned about the increasing epidemic of opioids throughout the US. I felt that cannabis products could be a better option.

What is your mission?

I want to make cannabis part of mainstream conversation. Our aim at RMR Laboratories is to be the first mass-market cannabis company with products you can use and go about your day. Once the industry is deregulated and cannabis is descheduled at the federal level, we’ll be poised to be the industry leader.

The ideal is for our products to become a safe, effective, and convenient therapy that everyone can access. On top of that, I would love to see cannabis become the first line of therapy, prior to opioids and other mind-altering painkillers.

I think it’s rare to have a team with this amount of subject matter depth and I feel humbled to work with them every day.

Who is in your core team? How did your team come together?

We have an exciting core team of four. Will and Leila are the marketing leads. Together, they have built startups, launched health and wellness products, and managed international brands. Leila owns Brand & Consumer Research and Will runs our Marketing Technology. I met Leila while we were both getting our MBAs at UCLA. Will and I connected through a mutual friend and we bonded quickly from our mutual appreciation of the outdoors and sports. He’s a serial entrepreneur with an MBA from Wharton.

Ryan leads R&D for us and he’s a life sciences rockstar. In addition to being a doctor, he was also a partner at McKinsey.

I think it’s rare to have a team with this amount of subject matter depth and I feel humbled to work with them every day.

We couple technology and science underlying our products with clinical data that shows how our products are different and effective.

What is your edge over your competition?

Instead of other methods, our product introduces the cannabinoid active ingredients into your body through topical skin cream. Our technology is a game changer. By delivering active ingredients through the skin, we remove barriers to product development. Consequently, we can change our formulation to address different health ailments and provide different concentrations.

Another key differentiator is the robust data at the core of our work. We couple technology and science underlying our products with clinical data that shows how our products are different and effective. RMR technology is covered by a strong patent portfolio and has been clinically validated through 15 Institutional Review Board (IRB) studies.

Looking ahead, we have a long roadmap for our topical category, starting with chronic pain and sports injuries and progressing to areas such as anxiety and insomnia. The current plan is to go to market with CBD-based chronic and sports pain creams.

Any challenges you anticipate? How do you plan to approach them?

As a startup, we have to ruthlessly prioritize and learn fast. Fortunately, I have a great team that pushes each other and the company in a healthy direction.

Second, we need to educate customers about how our product works as a topical therapy, which can prove to be a challenging task. The skin is designed to keep things out of the body. As a result, most topicals currently on the market don’t do anything, or simply mask the pain with things like menthol (a skin cooling agent). We counter this challenge by clearly explaining how our technology and products work.

As for the industry, there will be a time when the state and federal regulations converge. When that happens, RMR will be well-positioned as our product development is geared towards the mass market. Until then, we are still in a position to lead the market, but we need to be smart about how we grow and how we set up our production and distribution. 

Favorite book? Why?

I enjoy reading nonfiction to better understand the world around me. I recently re-read Sapiens, by Yuval Noah Harari. It helped me fill in some gaps for how people and societies act.

Another all-time favorite book is Thinking: Fast and Slow by Daniel Kahneman. If you read these two books and really absorb the concepts in them, I think you can understand most of human behavior. The only problem is that you have to be able to analyze and apply the concepts in real-time. That’s a whole other issue that I think can only be solved through practice, feedback and reflection.

As legalization picks up, the best talent will want to come work in the industry. It will be one of the fastest growing talent pools because it’s one of the fastest growing industries dealing with interesting, relevant problems.

How do you see your industry changing in the next five years?

I expect cannabis to become more and more accepted. Professional sports organizations like the World Anti-Doping Association (WADA) has already said that CBD will be legal for athletes in 2018. WADA influences much of the policy for the Olympics, which means countries all over the world will begin looking at CBD for therapeutics purposes. As elite athletes are always looking for an edge, I’m excited to expand our reach within elite athletes and we’ve been seeing great traction so far.

Second, there are opportunities for operational excellence, marketing, and digital technology. As legalization picks up, the best talent will want to come work in the industry. It will be one of the fastest growing talent pools because it’s one of the fastest growing industries dealing with interesting, relevant problems. On the flip side, there will be a shakeout in different areas of the cannabis value chain from growers to retailers. While the current market is much like the “wild west” in terms of organization, competition will cause dominant business models to arise. Staying differentiated will be key.

If you never had to work another day in your life, what would you do? Why?

I’d spend half my time in nature and the other half teaching. It’s only me and my dog now so I think I could pull that off. When I have a family, I think I’ll still spend half my time teaching, but I’ll have to plan how to drag them out into nature for weeks at a time.

I draw strength and motivation from people that aren’t in the spotlight.

An entrepreneur who inspires you?

Not any of the typical famous ones that develop electric cars or massive e-commerce companies, although they are very impressive. I draw strength and motivation from people that aren’t in the spotlight. I think about the people that toil day-in and day-out for no recognition other than the satisfaction that they provide for their families. I think these folks are no less innovative or bring any less potential than the most well-known entrepreneurs out there.

Something you can’t live without (other than your cell phone)?

A comfortable bed. Rest is under-appreciated. That said, I can fall asleep pretty much anywhere so I’m just saying a comfortable bed to make a point that rest is as important as active practices.

Why equity crowdfunding?

The products developed at RMR Laboratories will benefit thousands, if not millions of people. Why not give them the opportunity to share the success of our company? We are in the first few pages of a huge new story in the cannabis industry and I like the idea of writing it with everyday individual investors.

Share this story

Read next

From Uranium to Treasuries: How Etherlink is Unlocking Real-World Assets

Digital assets

From Uranium to Treasuries: How Etherlink is Unlocking Real-World Assets

The Real World Assets (RWA) sector has become one of the fastest-growing narratives in blockchain. In 2026, tokenized real-world assets are bridging traditional finance and decentralized technology, offering investors new levels of liquidity, transparency,...

Early Conviction to Enterprise Scale: Inside Republic’s Seven-Year Space Investment Pipeline

Republic

Early Conviction to Enterprise Scale: Inside Republic’s Seven-Year Space Investment Pipeline

Republic moved quickly to take part in the new space revolution’s earliest days, placing its first investment in May 2019. That early conviction has never wavered. Branches across Republic have offered dozens of investment opportunities throughout the ...

May Portfolio Update

Republic

May Portfolio Update

New funding rounds, international rollouts, acquisitions, and infrastructure partnerships. Catch up on the latest news from portcos.

4 comments

Share feedback and comment below. Please note that this section is not monitored by Republic. If you have any questions please reach out to investors@republic.co
The comment you're trying to see no longer exists.
Profile picture of ROGER TETRAULT
ROGER TETRAULT
8 years ago
Your ambitious goals will be a boon to an suffering problem world wide. The methods you use will be well accepted by the masses as it is an ingenious way to administer it.
1 like Reply
Profile picture of Leinani Cambra
Leinani Cambra
8 years ago
This is a great & impactful article. I love your vision of wanting to help so many people with various ailments that could truly benefit from cannabis. I honestly support the legalization of cannabis use in our nation. Cannabis can benefit so many people within so many aspects, health wise and economically. Keep working toward achieving your vision, it'll be a success!!
1 like Reply
Profile picture of Dorothy Widner
Dorothy Widner
8 years ago
Victoria: Beautiful article just like you! Hey, would you please ask Michael if he could his put proprietary patented Technology into a pill form for cancer patients or other cases? It sure would be great!
Thanks, Ricky
2 likes Reply
Profile picture of Michael  Lui
Michael Lui @dorothy-widner Hi. We are exploring oral applications, but health conditions like cancer are very complicated and there are rarely silver bullets. That said, there are other health conditions that we can pursue that will still provide benefit to thousands if not millions of people.
8 years ago
1 like
·
Reply
·
8 years ago
Profile picture of Martin Obono Jr
Martin Obono Jr
8 years ago
Well articulated article. Happy to have invested in the company that will champion the world to "develop health and wellness applications using cannabis derivatives."
2 likes Reply
Join the discussion
Icon
Verify your identity to join the discussion
To keep discussions authentic and prevent spam,
we ask users to verify their identity.
Verify your identity
Your information is kept secure and will only be used for identity verification.

Get notified about new posts

Not a valid email address
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Tokenized assets
Company
  • About
  • Insights
  • Events
  • Contact
  • Security
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC